In vivo and in vitro NASH models, GDF15 expression was upregulated in the hepatocytes, and its concentration was also increased with the progression of the disease, especially in subjects with advanced fibrosis (67). This evidence concerns the gene GDF15 and metabolic dysfunction-associated steatohepatitis.